These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8447792)

  • 1. Current issues in the treatment of hyperlipidaemias.
    Janus ED
    Aust Fam Physician; 1993 Feb; 22(2):212-4, 217, 220-1. PubMed ID: 8447792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quality of therapeutic control of hyperlipidemias in secondary prevention of coronary heart disease in the light of current recommendations].
    Mayer O; Mayer O
    Vnitr Lek; 2004 Oct; 50(10):777-80. PubMed ID: 15633934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidemia and coronary heart disease: management issues from Indian perspective.
    Gambhir DS; Gambhir JK; Sudha R
    Indian Heart J; 2000; 52(5):515-6, 617. PubMed ID: 11256772
    [No Abstract]   [Full Text] [Related]  

  • 4. The management of hyperlipidaemia.
    Dart AM
    Practitioner; 1987 May; 231(1429):657-8, 660-1, 664-5. PubMed ID: 3422898
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimal management of cholesterol levels and the prevention of coronary heart disease in women.
    Mosca LJ
    Am Fam Physician; 2002 Jan; 65(2):217-26. PubMed ID: 11820486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of dyslipidemia in primary care.
    Alzahrani T; Marrat S; Haider A
    Can J Cardiol; 2003 Dec; 19(13):1499-502. PubMed ID: 14760440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hyperlipidemia].
    Yoshino G
    Rinsho Byori; 2002 Mar; 50(3):254-61. PubMed ID: 11985052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of lipid disorders for coronary heart disease prevention according to International Atherosclerosis Society recommendations].
    Idzior-Waluś B
    Przegl Lek; 1999; 56(5):372-6. PubMed ID: 10554575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the management of hyperlipidaemia in general practice. Towards the primary prevention of coronary heart disease. Royal College of General Practitioners.
    Occas Pap R Coll Gen Pract; 1992 Mar; (55):1-15. PubMed ID: 1296829
    [No Abstract]   [Full Text] [Related]  

  • 10. Choosing the most appropriate therapy for lipid disorders.
    Simons LA
    Aust Fam Physician; 2000 Mar; 29(3):199-203. PubMed ID: 10785984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hyperlipidaemia.
    Stocks N; Allan J; Mansfield PR
    Aust Fam Physician; 2005 Jun; 34(6):447-53. PubMed ID: 15931403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hyperlipidemias.
    Cox RA
    Bol Asoc Med P R; 2003; 95(5):36-44. PubMed ID: 15008360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)?
    Sherrod JP; Krist A
    J Fam Pract; 2001 Nov; 50(11):928. PubMed ID: 11711006
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholesterol: precursor to many lipid disorders.
    Jones PH
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inadequate management of dyslipidaemic patients in France. Results of the Odyssée study].
    Ferrières J; Elbaz M; Maupas E; Carriè D; Puel J
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):187-93. PubMed ID: 15106741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the treatment of hyperlipidemia as secondary prevention adequate in different age groups in Israel?
    Shilo L; Feldman J; Gendlman V; Shenkman L; Berner YN
    Isr Med Assoc J; 2003 Jul; 5(7):479-81. PubMed ID: 12901241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-lowering therapy and the patient with multiple risk factors: what have we learned from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)?
    Sever PS
    Am J Med; 2005 Dec; 118 Suppl 12A():3-9. PubMed ID: 16356801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy for dyslipidemia.
    Spellman CW
    J Am Osteopath Assoc; 2003 Jan; 103(1 Suppl 1):S9-11. PubMed ID: 12572624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of reasons for discontinuation of treatment for dyslipidemia in secondary prevention of coronary heart disease].
    Tyszecka G
    Przegl Lek; 1999; 56(11):709-15. PubMed ID: 10800583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary prevention remains expensive, notwithstanding the consensus on lowering serum cholesterol levels].
    Bonneux L; Barendregt JJ
    Ned Tijdschr Geneeskd; 1999 Apr; 143(15):772-5. PubMed ID: 10347637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.